Assiste.Forums

Hi, The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal. According to the study of 108 adults, the vaccine produced neutralising a...